A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
Clinical trial NCT06621173 · RECRUITING
Trial details
- NCT number
- NCT06621173
- Sponsor
- Shanghai Changzheng Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-07-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.